CN112315820A - Oil-in-water sunscreen emulsion and preparation method thereof - Google Patents
Oil-in-water sunscreen emulsion and preparation method thereof Download PDFInfo
- Publication number
- CN112315820A CN112315820A CN202011406371.1A CN202011406371A CN112315820A CN 112315820 A CN112315820 A CN 112315820A CN 202011406371 A CN202011406371 A CN 202011406371A CN 112315820 A CN112315820 A CN 112315820A
- Authority
- CN
- China
- Prior art keywords
- oil
- component
- group
- water
- sunscreen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 124
- 229910001868 water Inorganic materials 0.000 title claims abstract description 124
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 85
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 65
- 239000000839 emulsion Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 238000004945 emulsification Methods 0.000 title description 3
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 32
- 239000004519 grease Substances 0.000 claims abstract description 21
- -1 skin feel regulator Substances 0.000 claims abstract description 19
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 239000012875 nonionic emulsifier Substances 0.000 claims abstract description 7
- 239000012071 phase Substances 0.000 claims description 70
- 239000000203 mixture Substances 0.000 claims description 43
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 35
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 35
- 238000003756 stirring Methods 0.000 claims description 35
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 21
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 21
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 21
- 239000000230 xanthan gum Substances 0.000 claims description 19
- 229920001285 xanthan gum Polymers 0.000 claims description 19
- 235000010493 xanthan gum Nutrition 0.000 claims description 19
- 229940082509 xanthan gum Drugs 0.000 claims description 19
- PFHLGILELJGQSJ-UHFFFAOYSA-N 4-(2h-benzotriazol-4-ylmethyl)-2h-benzotriazole;2-butyl-3,4,5,6-tetramethylphenol Chemical compound CCCCC1=C(C)C(C)=C(C)C(C)=C1O.C=1C=CC=2NN=NC=2C=1CC1=CC=CC2=C1N=NN2 PFHLGILELJGQSJ-UHFFFAOYSA-N 0.000 claims description 18
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 18
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000377 silicon dioxide Substances 0.000 claims description 17
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 229920002125 Sokalan® Polymers 0.000 claims description 15
- 229960001631 carbomer Drugs 0.000 claims description 15
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 15
- 230000001804 emulsifying effect Effects 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 15
- 229960005323 phenoxyethanol Drugs 0.000 claims description 15
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 14
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 13
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 13
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 13
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 12
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 12
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 12
- 229960001679 octinoxate Drugs 0.000 claims description 12
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 11
- 229930182478 glucoside Natural products 0.000 claims description 11
- 150000008131 glucosides Chemical class 0.000 claims description 11
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 11
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 10
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 10
- 229960004881 homosalate Drugs 0.000 claims description 10
- 239000003607 modifier Substances 0.000 claims description 10
- 229940100460 peg-100 stearate Drugs 0.000 claims description 10
- 229960000601 octocrylene Drugs 0.000 claims description 9
- 229940075529 glyceryl stearate Drugs 0.000 claims description 7
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 1
- 239000003921 oil Substances 0.000 abstract description 64
- 239000000126 substance Substances 0.000 abstract description 22
- 239000002537 cosmetic Substances 0.000 abstract description 13
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract description 6
- 229910052710 silicon Inorganic materials 0.000 abstract description 6
- 239000010703 silicon Substances 0.000 abstract description 6
- 230000000638 stimulation Effects 0.000 abstract description 3
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000002425 crystallisation Methods 0.000 abstract description 2
- 230000008025 crystallization Effects 0.000 abstract description 2
- 238000001556 precipitation Methods 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 60
- 210000003491 skin Anatomy 0.000 description 33
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 235000006708 antioxidants Nutrition 0.000 description 15
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 11
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 11
- 239000003755 preservative agent Substances 0.000 description 11
- 230000002335 preservative effect Effects 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 10
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000002562 thickening agent Substances 0.000 description 9
- 230000006641 stabilisation Effects 0.000 description 8
- 238000011105 stabilization Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 6
- 229940036350 bisabolol Drugs 0.000 description 6
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 6
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 4
- 229940049964 oleate Drugs 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000037072 sun protection Effects 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 3
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000001050 lubricating effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 229940047670 sodium acrylate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- VXLFMCZPFIKKDZ-UHFFFAOYSA-N (4-methylphenyl)thiourea Chemical compound CC1=CC=C(NC(N)=S)C=C1 VXLFMCZPFIKKDZ-UHFFFAOYSA-N 0.000 description 2
- 229940083957 1,2-butanediol Drugs 0.000 description 2
- PLRXBMPPQBKJQV-UHFFFAOYSA-N 1,3-bis(4-hydroxyphenyl)propan-2-one Chemical compound C1=CC(O)=CC=C1CC(=O)CC1=CC=C(O)C=C1 PLRXBMPPQBKJQV-UHFFFAOYSA-N 0.000 description 2
- MVNVIVWSAFEIII-UHFFFAOYSA-N 1-(4-hydroxyphenyl)ethanone Chemical compound CC(=O)C1=CC=C(O)C=C1.CC(=O)C1=CC=C(O)C=C1 MVNVIVWSAFEIII-UHFFFAOYSA-N 0.000 description 2
- 229940073735 4-hydroxy acetophenone Drugs 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OBJJEVJNCDBGOD-UHFFFAOYSA-N (+)-conicol Natural products C1=C(O)C=C2C3C=C(C)CCC3C(C)(C)OC2=C1 OBJJEVJNCDBGOD-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 235000008658 Artemisia capillaris Nutrition 0.000 description 1
- 241000092668 Artemisia capillaris Species 0.000 description 1
- 235000003069 Artemisia scoparia Nutrition 0.000 description 1
- 241001249148 Artemisia scoparia Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241000442274 Heteropappus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241001148118 Xanthomonas sp. Species 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 125000002138 bisabolol group Chemical group 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008407 cosmetic solvent Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000018883 loss of balance Diseases 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000000684 melanotic effect Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical group CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the field of cosmetics, and particularly relates to an oil-in-water sunscreen emulsion and a preparation method thereof. The oil-in-water sunscreen emulsion comprises, by weight, 45-60 parts of a group A water phase component, 35-45 parts of a group B oil phase component, 0.5-0.8 part of a group C component, 0.5-1.5 parts of a group D component and 15-20 parts of a group E component; the group B oil phase component is selected from one or more of organic sunscreen agent, grease, skin feel regulator, emulsifier and antioxidant; the emulsifier comprises an O/W type emulsifier with pH value of 5.5-7.5 and an O/W nonionic emulsifier with HLB value of 10-13 of 5 wt% aqueous solution. The oil-in-water sun-blocking emulsion provided by the invention has strong sun-blocking capability, no stimulation to human bodies, excellent compatibility to silicon oil substances, difficult crystallization and precipitation, easy film formation, safe use, good touch and fresh skin feel.
Description
Technical Field
The invention belongs to the field of cosmetics, and particularly relates to an oil-in-water sunscreen emulsion and a preparation method thereof.
Background
Sunlight is a well-established cause of photodamage, photoaging and skin cancer, and consists of Ultraviolet (UV) (290-400nm), visible (400-700nm) and infrared (> 700nm), with 5% reaching the earth's surface being UV radiation and a lesser proportion penetrating the atmosphere onto human skin. The effects of ultraviolet light on the skin include erythema, tanning, drug induced phototoxicity, photoaging, and non-melanotic skin cancers, among others. In recent years, the more the air pollution, the more the ozone layer thinning cavity causes the damage of ultraviolet rays to the skin. It is therefore desirable to protect our skin with sunscreen products.
For emulsion type sunscreen products, two general types of emulsion systems can be distinguished: oil-in-water type, water-in-oil type. The oil-in-water sunscreen product usually has heavy skin feel and is sticky due to high-content oil and large-molecular-weight main emulsifier in the external phase, and the experience of consumers is not good when the sunscreen product is used in summer. The oil-in-water type emulsion has a great advantage in summer due to its water-moist feeling. However, many oil-in-water emulsion cosmetics have poor water resistance as compared with oil-in-water emulsion products. Particularly in summer, people easily sweat or frequently soak in water for swimming, and the sun-proof product has more chance of being exposed to water. Oil-in-water type cosmetics are more likely to cause the loss of the ultraviolet ray protection agent due to poor water resistance, thereby reducing the ultraviolet ray protection function of sunscreen products. In the research and development of oil-in-water emulsion cosmetics, most of researches are focused on improving the water resistance, and the researches on simultaneously improving the water resistance and the sun protection index are less.
Therefore, it is very important to develop an oil-in-water sunscreen having good touch, high sun protection index and strong water resistance.
Disclosure of Invention
In order to solve the defects and deficiencies of the prior art, the invention provides in a first aspect an oil-in-water sunscreen emulsion, which comprises, by weight, 45-60 parts of a group A water phase component, 35-45 parts of a group B oil phase component, 0.5-0.8 part of a group C component, 0.5-1.5 parts of a group D component and 15-20 parts of a group E component; the group B oil phase component is selected from one or more of organic sunscreen agent, grease, skin feel regulator, emulsifier and antioxidant; the emulsifier comprises an O/W nonionic emulsifier with HLB value of 10-13.
In a preferable technical scheme, in the group B oil phase component, the mass ratio of the organic sunscreen agent, the grease, the skin feel conditioning agent, the emulsifier and the antioxidant is (20-26): (8-12): (0.01-0.1): (3-5): (0.05-0.15).
As a preferable technical scheme, the organic sunscreen agent is selected from one or more of ethylhexyl methoxycinnamate, homosalate, octocrylene, ethylhexyl salicylate, diethyl amino hydroxybenzoyl hexyl formate and bis-ethyl hexyloxy phenol methoxyphenyl triazine.
As a preferred embodiment, the emulsifier further comprises cetearyl glucoside and cetearyl alcohol.
As a preferable technical scheme, the O/W nonionic emulsifier with the HLB value of 10-13 is glycerol stearate and PEG-100 stearate.
As a preferable technical scheme, the grease comprises one or more of cyclopentadimethyl siloxane, isononyl isononanoate, C12-15 alcohol benzoate and hydrogenated polyisobutene.
As a preferred technical scheme, the group a water phase component comprises water, glycerol, butanediol, carbomer, xanthan gum and sodium hyaluronate; the mass ratio of the water, the glycerin, the butanediol, the carbomer, the xanthan gum and the sodium hyaluronate is (30-40): (2-4): (1-3): (0.1-0.2): (0.1-0.3): (0.01-0.03).
As a preferable technical scheme, the component E is one or more selected from phenoxyethanol, dipotassium glycyrrhizinate, silica and methylene bis-benzotriazole tetramethyl butyl phenol.
As a preferable technical scheme, the mass ratio of the phenoxyethanol to the dipotassium glycyrrhizinate to the silica to the methylene bis-benzotriazole tetramethyl butylphenol is (0.2-0.4): (0.05-0.15): (2-4): (4-6).
The second aspect of the invention provides a preparation method of the oil-in-water sunscreen emulsion, which comprises the following steps:
s1: adding the water phase components of group A into an emulsifying pot, heating to 80-85 deg.C, stirring and homogenizing to completely dissolve;
s2: adding the group B oil phase components into an oil phase pot, heating to 80-85 ℃, and stirring to completely dissolve the group B oil phase components;
s3: adding the group B oil phase component treated by the S2 into the group A water phase component treated by the S2, homogenizing and emulsifying uniformly, stirring and cooling to 55-65 ℃ to obtain a mixture 1;
s4: adding the component C into the mixture 1 obtained in the step S3, stirring and homogenizing until the component C is completely dissolved, and continuously cooling to 40-50 ℃ to obtain a mixture 2;
s5: mixing and dissolving the component D completely, then adding the component D into the mixture 2 obtained in the step S4, and stirring and mixing the component D until the component D is completely dissolved to obtain a mixture 3;
s6: pre-dispersing methylene bis-benzotriazole tetramethyl butyl phenol by water according to a ratio of 1:2, adding the component E into the mixture 3 obtained in the step S5, and stirring and mixing until the component E is completely dissolved to obtain the oil-in-water sun-block emulsion.
Has the advantages that: the oil-in-water sun-screen emulsion provided by the invention can achieve full-wavelength protection and protection of skin by absorbing and blocking the wavelengths in UVA and UVB ranges, has strong sun-screen capability, has no stimulation to human body, has excellent compatibility with silicon oil substances, is not easy to crystallize and separate out, is easy to form a film, is safe to use, and has good and refreshing skin feel.
Detailed Description
The technical features of the technical solutions provided by the present invention are further clearly and completely described below with reference to the specific embodiments, and the scope of protection is not limited thereto.
When an amount, concentration, or other value or parameter is expressed as a range, preferred range, or as a range of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when the range "1 to 5" is disclosed, the described range should be construed as including the ranges "1 to 4", "1 to 3", "1 to 2", "2 to 3" and "3 to 4", "4 to 5" and "3 to 5", etc. When a range of values is described herein, unless otherwise stated, the range is intended to include the endpoints thereof and all integers and fractions within the range.
The singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. "optional" or "any" means that the subsequently described event or events may or may not occur, and that the description includes instances where the event occurs and instances where it does not.
In addition, the indefinite articles "a" and "an" preceding an element or component of the invention are not intended to limit the number requirement (i.e., the number of occurrences) of the element or component. Thus, "a" or "an" should be read to include one or at least one, and the singular form of an element or component also includes the plural unless the stated number clearly indicates that the singular form is intended.
In order to solve the technical problems, the invention provides an oil-in-water sunscreen emulsion which comprises, by weight, 45-60 parts of a group A water phase component, 35-45 parts of a group B oil phase component, 0.5-0.8 part of a group C component, 0.5-1.5 parts of a group D component and 15-20 parts of a group E component; the group B oil phase component is selected from one or more of organic sunscreen agent, grease, skin feel regulator, emulsifier and antioxidant; the emulsifier comprises an O/W nonionic emulsifier with HLB value of 10-13.
In one embodiment, the oil-in-water sunscreen emulsion comprises 52 parts of a group A water phase component, 40 parts of a group B oil phase component, 0.6 part of a group C component, 1 part of a group D component and 17 parts of a group E component in parts by weight.
Group A aqueous phase component
In one embodiment, the group a aqueous phase components include water, glycerin, butylene glycol, carbomer, xanthan gum, sodium hyaluronate; the mass ratio of the water, the glycerin, the butanediol, the carbomer, the xanthan gum and the sodium hyaluronate is (30-40): (2-4): (1-3): (0.1-0.2): (0.1-0.3): (0.01-0.03); preferably, the mass ratio of the water to the glycerin to the butanediol to the carbomer to the xanthan gum to the sodium hyaluronate is 34: 3: 4: 0.15: 0.2: 0.02.
(Water)
In the invention, the water is deionized water.
(Glycerol)
In the invention, the glycerin is colorless, transparent, odorless and viscous liquid, tastes sweet and has hygroscopicity. Mixing with water and alcohols, amines and phenols in any ratio, and making the aqueous solution neutral.
(butanediol)
In the invention, the butanediol is 1, 2-butanediol.
(Carbonic acid)
In the invention, the carbomer is TR-1 and is purchased from Lumbo corporation.
TR-1 is a multifunctional polymer that emulsifies 30% oil by weight at a pH ranging from 4 to 5.5 and 20% oil at a pH ranging from 3 to 11.
(Xanthan gum)
In the present invention, the xanthan gum, also known as xanthan gum, is an extracellular acidic heteropolysaccharide produced by fermentation of xanthomonas sp. Is prepared from D-glucose, D-mannose and D-glucuronic acid in a weight ratio of 2: 2: 1, the relative molecular mass of the polysaccharide polymer compound is more than 100 ten thousand. The secondary structure of xanthan gum is that the side chain winds around the main chain skeleton reversely, and a rodlike double-spiral structure is formed through a hydrogen bond system. It has unique rheological property, good water solubility, good stability to heat and acid and alkali, and good compatibility with various salts, and can be used as thickener, suspending agent, emulsifier, and stabilizer.
The xanthan gum is reversely wound around the main chain skeleton due to the side chain, forms a rod-shaped double-spiral structure through a hydrogen bond system, can be used as a thickening agent, a suspending agent and an emulsifying agent, has synergistic effect with carbomer, sodium hyaluronate and the like, provides a consistency with less pH influence for a system, has good skin feel and is beneficial to improving the stability of the system.
In the invention, the xanthan gum is given by the brand numberXGN, purchased from New chemical industries, Inc.
(sodium hyaluronate)
In the invention, the sodium hyaluronate has the chemical formula of (C)14H20NO11Na) n, an inherent component in human body, is a glucan aldehyde acid, has no species specificity, and is widely present in tissues such as placenta, amniotic fluid, crystalline lens, articular cartilage, skin dermis and the like; it is distributed in the cytoplasm and the intercellular substance of the organ, and plays a role in lubricating and nourishing the cells and the organelles contained therein. Sodium hyaluronate belongs to high molecular polymer and has strong lubricating feeling and film forming property. The skin care product containing sodium hyaluronate has obvious lubrication feeling and good hand feeling when being smeared. After being applied to the skin, a layer of film can be formed on the surface of the skin, so that the skin can generate good smooth feeling and moist feeling, and the protective effect on the skin is achieved.
In one embodiment, the sodium hyaluronate is available under the trade designation Hybloom sodium hyaluronate (HA-T) and purchased from Huaxi Biotech.
Group B oil phase component
In one embodiment, the group B oil phase component is a mixture of organic sunscreens, oils, skin feel modifiers, emulsifiers, antioxidants.
In a preferred embodiment, in the group B oil phase component, the mass ratio of the organic sunscreen agent, the grease, the skin-feel modifier, the emulsifier and the antioxidant is (20-26): (8-12): (0.01-0.1): (3-5): (0.05-0.15); more preferably, in the group B oil phase component, the mass ratio of the organic sunscreen agent, the grease, the skin feel modifier, the emulsifier and the antioxidant is 25.5: 10: 0.05: 4: 0.1.
(organic sunscreen agent)
In one embodiment, the organic sunscreen agent is selected from one or more of ethylhexyl methoxycinnamate, homosalate, octocrylene, ethylhexyl salicylate, hexyl diethylaminobenzoyl formate, bis-ethylhexyloxyphenol methoxyphenyl triazine; preferably, the organic sunscreen agent is a mixture of ethylhexyl methoxycinnamate, homosalate, octocrylene, ethylhexyl salicylate, hexyl diethylamino hydroxybenzoyl formate, bis-ethylhexyloxyphenol methoxyphenyl triazine.
In a preferred embodiment, the mass ratio of the ethylhexyl methoxycinnamate, homosalate, octocrylene, ethylhexyl salicylate, hexyl diethylamino hydroxybenzoyl formate, bis-ethylhexyloxyphenol methoxyphenyl triazine is 9: 2: 5: 5: 3: 1.5.
the invention adopts ethylhexyl methoxycinnamate, homosalate, octocrylene, ethylhexyl salicylate, diethyl-amino-hydroxybenzoyl hexyl formate and bis-ethylhexyloxyphenol methoxyphenyl triazine as organic sun-screening agents, and the mass ratio is controlled to be 9: 2: 5: 5: 3: 1.5, can reduce the damage to the skin, has no irritation, and does not produce toxic metabolites. The sunscreen lotion has strong sunscreen capacity, is applied to oil-in-water sunscreen lotion, has good oil compatibility, is not greasy, is quick in film forming and is not easy to crystallize and separate out.
In the invention, the ethylhexyl methoxycinnamate is colorless to light yellow viscous liquid, is insoluble in water, is soluble in organic solvents such as ethanol and the like, has good oil solubility, and is suitable for being stored in a closed place in the shade. Ethylhexyl methoxycinnamate is a good absorber in the ultraviolet UVB region and is effective in preventing280-310nm ultraviolet rays and high absorptivity. Has no stimulation to skin and good safety, and is almost an ideal sunscreen emulsion. CAS number 5466-77-3, chemical formula C18H26O3The structural formula is as follows:
the invention adopts ethylhexyl methoxycinnamate which can be used as a penetration enhancer and can be easily absorbed by skin. The maximum addition level, which is defined by national and european union regulations, is 10 wt%.
In the invention, the homosalate is represented by the chemical formula C16H22O3CAS number: 118-56-9, is a colorless transparent liquid chemical substance, is insoluble in water, can absorb ultraviolet rays in the UVB 295-315 wave band, and is mainly used for ultraviolet UVB sun-screening milk in industry. The amount should not exceed 10 wt%.
In the invention, the molecular formula of the ethylhexyl salicylate is C15H22O3CAS number 118-60-5.
In the present invention, the octocrylene, the oil-soluble ultraviolet absorber, is insoluble in water. It can help other oil soluble solid sunscreen emulsion to dissolve. The emulsion has the advantages of high absorptivity, no toxicity, no teratogenic action, good stability to light and heat and the like, can absorb UVB and a small amount of UVA, is a I-class sun block approved by the FDA in the United states, and has high use rate in the United states and Europe. CAS number 6197-30-4, molecular formula C24H27NO2。
In the present invention, the diethylaminohydroxybenzoylbenzoic acid hexyl ester (Diethylaminohydroxybenzoyl hexyl benzoate), also referred to as 4-tolylthiourea or p-methylphenylthiourea, is an ester compound having a relative molecular mass of 397.5072. CAS number 302776-68-7, formula C24H31NO4。
In the invention, the CAS number of the bis-ethylhexyloxyphenol methoxyphenyl triazine is 187393-00-6, and the molecular formula is C38H49N3O5Structural formula is
(oil and fat)
In a preferred embodiment, the grease comprises one or more of cyclopentadimethylsiloxane, isononyl isononanoate, C12-15 alcohol benzoate and hydrogenated polyisobutene.
In a preferred embodiment, the grease is a mixture of cyclopentadimethylsiloxane, isononyl isononanoate, C12-15 alcohol benzoate and hydrogenated polyisobutene; more preferably, the weight ratio of the cyclopentadimethylsiloxane, the isononyl isononanoate, the C12-15 alcohol benzoate and the hydrogenated polyisobutene is 3: 3: 2: 2.
the invention adopts the combination of cyclopentadimethyl siloxane, isononyl isononanoate, C12-15 alcohol benzoate and hydrogenated polyisobutene as grease, and the grease and the emulsifiers of cetearyl glucoside, cetearyl alcohol, glycerol stearate and PEG-100 stearate have the same effect, so that good touch feeling can be kept. And C12-15 alcohol benzoate, liquid grease have strong polarity, can effectively dissolve organic sunscreen agent, effectively reduce the possibility of crystallization, isononyl isononanoate is nonpolar grease containing multi-methyl branched chain structure, has excellent compatibility to silicon oil substances, and thus solves the problem that cyclopenta dimethyl silicone polymer and sunscreen emulsion are mutually insoluble.
In the invention, the cyclopentasiloxane has the name of: decamethylcyclopentasiloxane, cyclopentasiloxane, decamethylcyclopentasiloxane (D5). CAS number 541-02-6, molecular formula C10H30O5Si5. Under the designation SF1202, purchased from mayonnaise corp.
In the invention, the isononyl isononanoate has a molecular formula of C18H36O2CAS number: 42131-25-9. Commonly known as synthetic silk oil.
The invention adopts isononyl isononanoate, unique multi-methyl branched chain structure, silky feeling, dry and comfortable and extremely soft hand feeling, and excellent emollient. The silicon oil stabilizer and the coupling agent have good compatibility with silicon oil, can solve the problem of low-temperature precipitation of the silicon oil. Has good dispersion ability for pigment, low viscosity, refreshing skin feeling, and no greasy feeling. Odd-numbered mid-chain branched alcohols are colorless, odorless, liquid monoesters with odd-numbered mid-chain branched fatty acids and have low viscosities.
In the invention, the C12-15 alcohol benzoate is available from New-Ann chemical trade company of Foshan under the CAS number of 68411-27-8 and AB 25.
The invention adopts C12-15 alcohol benzoate, has good dissolving capacity and toner dispersing capacity, has fresh skin feel, and is particularly suitable for being used as a sunscreen product. The oil-soluble sun-screening emulsion pigment, the poly-C siloxane and other components are easy to dissolve in C12-15 alcohol benzoate and easy to emulsify, and the greasy feeling can be obviously overcome by adding a small amount of the ester.
In the invention, the hydrogenated polyisobutene is a synthetic polymer and is mainly used as a film forming agent, a softening agent and a viscosity control agent in cosmetics. Hydrogenated polyisobutenes have the cosmetic properties of squalane and are therefore referred to as synthetic squalane. The isomeric straight chain alkane can be used as oil phase component of cosmetics and medicines, has moistening, moisturizing and lubricating effects, and has properties similar to natural squalane; the hydrogenated polyisobutene is purchased from cypress picture chemical technology ltd, guangzhou.
(skin-feel modifier)
In one embodiment, the skin feel modifier is selected from one or more of dextran, hyaluronic acid/sodium hyaluronate, pullulan, sodium alginate, xanthan gum, glucose, trehalose, fructose, maltose, bisabolol; preferably, the skin feel modifier is bisabolol.
In the invention, the bisabolol is a component existing in the chamomile, and the anti-inflammatory effect of the chamomile is mainly derived from the bisabolol. Bisabolol is colorless to glutinous liquid of rice straw yellow, and is soluble in lower alcohol (ethanol, isopropanol), fatty alcohol, glyceride and vinegar, and hardly soluble in water and glycerol.
In one embodiment, the bisabolol is α -bisabolol.
In the present invention, the α -bisabolol has a chemical formula C15H26O, CAS number515-69-5, structural formula:
the invention adopts alpha-bisabolol as a skin feel regulator, has good stability and excellent skin compatibility, and not only has anti-inflammatory performance, but also is proved to have bacteriostatic activity. The alpha-bisabolol does not change color after long-term storage.
(emulsifiers)
In one embodiment, the emulsifier further comprises cetearyl glucoside and cetearyl alcohol.
In one embodiment, the cetearyl glucoside and cetearyl alcohol are available under the brand name M68, available from behabo corporation.
In the invention, the cetearyl glucoside and the cetearyl alcohol are O/W type emulsifiers with self-emulsifying and self-thickening functions, oleophylic fat groups and hydrophilic glucose groups of the O/W type emulsifiers are both plant sources, and the O/W type emulsifiers do not contain solvents and irritant by-products, have excellent emulsifying performance, promote the formation of liquid crystals in a formula system, and can endow the product with excellent smooth and plump skin feeling, and unique use effects of moisturizing and slow-release functional components. In the cooling process after emulsification, the liquid crystal of the system is gradually formed, and strong stirring is avoided so as not to damage the ordered structure of the liquid crystal.
In one embodiment, the O/W nonionic emulsifier having an HLB value of 10 to 13 is glyceryl stearate and PEG-100 stearate, available from Daiichi corporation under the trademark ARLACEL 170-PA- (SG).
In a preferred embodiment, the mass ratio of cetearyl glucoside to cetearyl alcohol, glyceryl stearate and PEG-100 stearate is 2: 2.
in the present invention, the HLB value: the surfactant is an amphiphilic molecule with a hydrophilic group and a lipophilic group, and the amount of the size and the force balance degree between the hydrophilic group and the lipophilic group in the surfactant molecule is defined as the hydrophilic-lipophilic balance value of the surfactant.
In the invention, the HLB value of the glycerol stearate and the PEG-100 stearate is 11.2, the acid value (mg KOH/g) is less than or equal to 3.0, and the saponification value (mg KOH/g) is 80-100. Can be used alone or as auxiliary emulsifier, has strong emulsifying ability, excellent stability in weakly acidic and electrolyte-containing formulas, and good compatibility with most cosmetic components and medicinal components. Has good emulsifying capacity to polar and non-polar grease, and the emulsified paste has fine and bright appearance, good spreadability and easy application.
In the present invention, the acid value represents the number of milligrams of potassium hydroxide (KOH) required to neutralize 1 gram of chemical substance.
In the present invention, the saponification value represents the number of milligrams of potassium hydroxide consumed by alkaline hydrolysis of 1g of fats and oils.
(antioxidant)
In one embodiment, the antioxidant is selected from one or more of tocopheryl acetate, dibutyl hydroxy toluene, butyl hydroxy anisole; preferably, the antioxidant is tocopherol acetate.
In the invention, the tocopherol acetate is easily soluble in chloroform, diethyl ether, acetone and vegetable oil, is soluble in alcohol and is insoluble in water. Has good heat resistance, can be oxidized when being exposed to light, has dark color and belongs to vitamin E derivatives. Tocopherol acetate is not only skin regulator, but also antioxidant, and has protective effect of preventing skin injury due to sunlight and ultraviolet when used in cosmetic. Signs of aging, such as skin aging and damage, are often associated with free radical damage, as this can result in a loss of balance in native sebum and collagen production.
Component C
In one embodiment, the C component includes a thickener and a pH adjuster; the mass ratio of the thickening agent to the pH regulator is 5: 1.
in one embodiment, the thickener is ethylhexyl olivate, sodium acrylate copolymer, polyglycerol-4 oleate sold under the trademark Olivem 2020G, available from Ronghai Biotech, Inc.
According to the invention, the olive oil acid ethylhexyl ester, the acrylic acid (ester) copolymer sodium and the polyglycerol-4 oleate are colorless to light yellow viscous liquid, contain 65% of natural components, can be suspended in a stable system, are clear in skin feel, are not sticky, are bright and white in paste body, and have moisturizing performance.
In one embodiment, the pH adjusting agent is triethanolamine.
In the invention, the triethanolamine, namely the tri (2-hydroxyethyl) amine, is an organic compound which can be regarded as a trihydroxy substituent of triethylamine and has a chemical formula of C6H15NO3. Similar to other amine compounds, because of the lone pair of electrons on the nitrogen atom, triethanolamine has weak alkalinity and can react with inorganic acid or organic acid to generate salt.
According to the invention, triethanolamine is adopted to achieve the application effects of thickening and moisturizing, the triethanolamine interacts with carbomer TR-1 in the group A water phase component to form a stable high molecular structure, so that the stability of the oil-in-water sunscreen emulsion is improved, and the triethanolamine interacts with an emulsifier, ethylhexyl olivate, sodium acrylate copolymer and polyglycerol-4 oleate to realize 2-week circulation and low-temperature demulsification-free phenomenon of the oil-in-water sunscreen emulsion, so that the triethanolamine is centrifuged without layering, the in-vitro sunscreen index is further improved, the greasy feeling is reduced, and the spreadability is improved.
Component of group D
In one embodiment, the group D component is a preservative combination; the preservative composition comprises a preservative and pentanediol, and the mass ratio of the preservative to the pentanediol is 0.4: 0.6.
in one embodiment, the preservative is selected from one or more of methylparaben, propylparaben, and p-hydroxyacetophenone; preferably, the preservative is p-hydroxyacetophenone.
In the invention, the p-Hydroxyacetophenone is also named 4-Hydroxyacetophenone (4-hydroxy acetophenone), 4-Acetylphenol (4-Acetylphenol), p-Acetylphenol (p-Acetylphenol), 4-hydroxyphenylmethyl ketone (4-hydroxyphenyl methyl ketone), commonly called conicol (picenol), is white needle-shaped crystal at normal temperature, is combustible, can be easily dissolved in hot water, methanol, ethanol, diethyl ether, acetone and benzene, and can be hardly dissolved in petroleumAnd (c) an ether. Is naturally present in stems and leaves of Artemisia scoparia of Compositae, and roots of Artemisia capillaris, Heteropappus japonica of Asclepiadaceae, etc. CAS number 99-93-4, molecular formula C8H8O2Chemical structural formula is
In the invention, the pentanediol is 1, 2-pentanediol, colorless transparent liquid with a chemical formula of C5H12O2Can be dissolved in organic solvents such as alcohol, ether and ethyl acetate, and is often applied to cosmetic solvents.
The invention adopts 1, 2-pentanediol, the pH regulator with excellent performance, and simultaneously has the function of antisepsis, reduces the allergy caused by p-hydroxyacetophenone, but has the special smell of alcohol, and can improve the water resistance of the oil-in-water sun-proof emulsion.
Component E
In one embodiment, the E component is selected from one or more of phenoxyethanol, dipotassium glycyrrhizinate, silica, methylene bis-benzotriazole tetramethylbutylphenol; preferably, the component E is a mixture of phenoxyethanol, dipotassium glycyrrhizinate, silica and methylene bis-benzotriazole tetramethyl butylphenol.
In a preferred embodiment, the mass ratio of the phenoxyethanol to the dipotassium glycyrrhizinate to the silica to the methylene bis-benzotriazole tetramethylbutylphenol is (0.2-0.4): (0.05-0.15): (2-4): (4-6); more preferably, the mass ratio of the phenoxyethanol to the dipotassium glycyrrhizinate to the silica to the methylene bis-benzotriazole tetramethylbutylphenol is 0.3: 0.1: 3: 5.
(Phenoxyethanol)
In the invention, the molecular formula of the phenoxyethanol is C8H10O2CAS number 122-99-6, structural formulaThe colorless slightly viscous liquid has aromatic odor, is slightly soluble in water, is easily soluble in ethanol and sodium hydroxide, and has antibacterial and antiseptic effects.
(dipotassium glycyrrhizinate)
In the invention, the dipotassium glycyrrhizinate is white or off-white fine powder, has the purity of 98 percent, has special sweet taste, good water solubility and pure mouthfeel. The dipotassium glycyrrhizinate has multiple effects of bacteriostasis, inflammation diminishing, detoxification, anti-allergy, deodorization and the like. Has wide application in the industries of medicine, cosmetics, daily chemicals, food and the like. CAS number: 68797-35-3, formula: c42H60K2O16。
(silica)
In the present invention, the silica is also called silicon dioxide or quartz sand.
In one embodiment, the silica has an oil absorption of 0.9 to 1.3cc/g, an average pore size of 1 to 3 μm, and is available under the trade name Sunsil-20W from Guangzhou HuaTu cosmetics science and technology, Inc.
(methylenebis-benzotriazoltetramethylbutylphenol)
In the present invention, the methylenebis-benzotriazoltetramethylbutylphenol, CAS No.: 103597-45-1, chemical sun-screening lotion. The Tinosorb M test has the same UV-shielding wavelength as Tinosorb S at 280-400nm, but the maximum protective efficacy occurs at both wavelengths 303nm and 358nm, thus having protective effects against both UV-A and UV-B.
The second aspect of the invention provides a preparation method of the oil-in-water sunscreen emulsion, which comprises the following steps:
s1: adding the water phase components of group A into an emulsifying pot, heating to 80-85 deg.C, stirring and homogenizing to completely dissolve;
s2: adding the group B oil phase components into an oil phase pot, heating to 80-85 ℃, and stirring to completely dissolve the group B oil phase components;
s3: adding the group B oil phase component treated by the S2 into the group A water phase component treated by the S2, homogenizing and emulsifying uniformly, stirring and cooling to 55-65 ℃ to obtain a mixture 1;
s4: adding the component C into the mixture 1 obtained in the step S3, stirring and homogenizing until the component C is completely dissolved, and continuously cooling to 40-50 ℃ to obtain a mixture 2;
s5: mixing and dissolving the component D completely, then adding the component D into the mixture 2 obtained in the step S4, and stirring and mixing the component D until the component D is completely dissolved to obtain a mixture 3;
s6: pre-dispersing methylene bis-benzotriazole tetramethyl butyl phenol by water according to a ratio of 1:2, adding the component E into the mixture 3 obtained in the step S5, and stirring and mixing until the component E is completely dissolved to obtain the oil-in-water sun-block emulsion.
In one embodiment, the method for preparing the oil-in-water sunscreen emulsion comprises the following steps:
s1: adding the water phase components of group A into an emulsifying pot, heating to 80-85 deg.C, stirring and homogenizing to completely dissolve;
s2: adding the group B oil phase components into an oil phase pot, heating to 80-85 ℃, and stirring to completely dissolve the group B oil phase components;
s3: adding the group B oil phase component treated by the S2 into the group A water phase component treated by the S2, homogenizing and emulsifying uniformly, stirring and cooling to 60 ℃ to obtain a mixture 1;
s4: adding the component C into the mixture 1 obtained in the step S3, stirring and homogenizing until the component C is completely dissolved, and continuously cooling to 45 ℃ to obtain a mixture 2;
s5: mixing and dissolving the component D completely, then adding the component D into the mixture 2 obtained in the step S4, and stirring and mixing the component D until the component D is completely dissolved to obtain a mixture 3;
s6: pre-dispersing methylene bis-benzotriazole tetramethyl butyl phenol by water according to a ratio of 1:2, adding the component E into the mixture 3 obtained in the step S5, and stirring and mixing until the component E is completely dissolved to obtain the oil-in-water sun-block emulsion.
The oil-in-water sunscreen emulsion prepared by the preparation method can effectively prevent emulsion breaking and oil yielding caused by adding the organic sunscreen agent into the water phase component, so that the stability of the oil-in-water sunscreen emulsion is improved strongly, the oil-in-water sunscreen emulsion cannot be layered under a centrifugal condition, and the water resistance of the oil-in-water sunscreen emulsion is greatly improved.
The present invention will be specifically described below by way of examples. It should be noted that the following examples are only for illustrating the present invention and should not be construed as limiting the scope of the present invention, and that the insubstantial modifications and adaptations of the present invention by those skilled in the art based on the above disclosure are still within the scope of the present invention.
In addition, the starting materials used are all commercially available, unless otherwise specified.
Examples
Example 1
Example 1 provides an oil-in-water sunscreen comprising, by weight, 45 parts of a group a water phase component, 35 parts of a group B oil phase component, 0.5 part of a group C component, 0.5 part of a group D component, 15 parts of a group E component;
the group A water phase component comprises water, glycerol, butanediol, carbomer, xanthan gum and sodium hyaluronate; the mass ratio of the water, the glycerin, the butanediol, the carbomer, the xanthan gum and the sodium hyaluronate is 30: 4: 3: 0.1: 0.1: 0.01; the butanediol is 1, 2-butanediol; carbomer is TR-1 and is purchased from Lumbo corporation; the xanthan gum is of the gradeXGN, purchased from New chemical industries, Inc.; the sodium hyaluronate is Hybloom sodium hyaluronate (HA-T) and purchased from Huaxi Biotech company;
the group B oil phase component is a mixture of an organic sunscreen agent, grease, a skin feel regulator, an emulsifier and an antioxidant; in the group B oil phase component, the mass ratio of the organic sunscreen agent, the grease, the skin feel regulator, the emulsifier and the antioxidant is 25.5: 10: 0.05: 4: 0.1; the organic sunscreen agent is a mixture of ethylhexyl methoxycinnamate, homosalate, ethylhexyl salicylate, octocrylene, diethyl aminooxybenzoyl hexyl formate, and bis-ethylhexyloxyphenol methoxyphenyl triazine; the mass ratio of the ethylhexyl methoxycinnamate, the homosalate, the ethylhexyl salicylate, the octocrylene, the diethyl amino hydroxybenzoyl hexyl formate to the bis-ethylhexyloxyphenol methoxyphenyl triazine is 9: 2: 5: 5.: 3: 1.5; the ethylhexyl methoxycinnamate CAS number 5466-77-3; the homosalate CAS number 118-56-9; the CAS number of the ethylhexyl salicylate is 118-60-5; the Okrill CAS number 6197-30-4; the CAS number of the diethylamino hydroxybenzoyl hexyl benzoate is 302776-68-7; the CAS number of the bis-ethylhexyloxyphenol methoxyphenyl triazine is 187393-00-6; the grease is a mixture of cyclopentadimethylsiloxane, isononyl isononanoate, C12-15 alcohol benzoate and hydrogenated polyisobutene; the mass ratio of the cyclopentadimethylsiloxane, isononyl isononanoate, C12-15 alcohol benzoate and hydrogenated polyisobutene is 3: 3: 2: 2; the cyclopentasiloxane, designated SF1202, was purchased from Mitigo, Inc.; the isononyl isononanoate CAS number 42131-25-9; the C12-15 alcohol benzoate with the brand number of AB25 is purchased from Xinan chemical trade company of Foshan; the hydrogenated polyisobutene is purchased from cypress diagram chemical technology, ltd, guangzhou; the skin feel modifier is alpha-bisabolol with CAS number 515-69-5; the emulsifier is a mixture of cetearyl glucoside and cetearyl alcohol, glyceryl stearate and PEG-100 stearate; the mass ratio of the cetearyl glucoside to the cetearyl alcohol, the glyceryl stearate to the PEG-100 stearate is 2: 2; the antioxidant is tocopherol acetate;
the component C comprises a thickening agent and a pH regulator; the mass ratio of the thickening agent to the pH regulator is 5: 1; the thickening agent is ethylhexyl olive oleate, sodium acrylate copolymer and polyglycerol-4 oleate, the mark is Olivem 2020G, and the thickening agent is purchased from Yonghai Biotech limited; the pH regulator is triethanolamine;
the component D is a preservative combination; the preservative composition comprises a preservative and pentanediol; the mass ratio of the preservative to the pentanediol is 0.4: 0.6; the preservative is p-hydroxyacetophenone with CAS number 99-93-4; the pentanediol is 1, 2-pentanediol;
the component E is a mixture of phenoxyethanol, dipotassium glycyrrhizinate, silica and methylene bis-benzotriazole tetramethyl butyl phenol; the mass ratio of the phenoxyethanol to the dipotassium glycyrrhizinate to the silica to the methylene bis-benzotriazole tetramethyl butylphenol is 0.2: 0.05: 2: 4; the CAS number of the phenoxyethanol is 122-99-6; the glycyrrhizic acid dipotassium CAS number 68797-35-3; the silica has an oil absorption of 0.9-1.3cc/g, an average pore diameter of 1-3 μm, a trade name of Sunsil-20W, and is available from Guangzhou Huatu cosmetics science and technology Limited; the methylene bis-benzotriazole tetramethylbutylphenol has CAS number 103597-45-1.
The preparation method of the oil-in-water sunscreen emulsion comprises the following steps:
s1: adding the water phase components of group A into an emulsifying pot, heating to 80-85 deg.C, stirring and homogenizing to completely dissolve;
s2: adding the group B oil phase components into an oil phase pot, heating to 80-85 ℃, and stirring to completely dissolve the group B oil phase components;
s3: adding the group B oil phase component treated by the S2 into the group A water phase component treated by the S2, homogenizing and emulsifying uniformly, stirring and cooling to 60 ℃ to obtain a mixture 1;
s4: adding the component C into the mixture 1 obtained in the step S3, stirring and homogenizing until the component C is completely dissolved, and continuously cooling to 45 ℃ to obtain a mixture 2;
s5: mixing and dissolving the component D completely, then adding the component D into the mixture 2 obtained in the step S4, and stirring and mixing the component D until the component D is completely dissolved to obtain a mixture 3;
s6: pre-dispersing methylene bis-benzotriazole tetramethyl butyl phenol by water according to a ratio of 1:2, adding the component E into the mixture 3 obtained in the step S5, and stirring and mixing until the component E is completely dissolved to obtain the oil-in-water sun-block emulsion.
Example 2
Embodiment 2 provides an oil-in-water sunscreen emulsion comprising, by weight, 60 parts of a group a water phase component, 45 parts of a group B oil phase component, 0.8 part of a group C component, 1.5 parts of a group D component, and 20 parts of a group E component;
the aqueous phase components of group a were the same as in example 1, except that the mass ratio of water, glycerin, butylene glycol, carbomer, xanthan gum, and sodium hyaluronate was 40: 4: 5: 0.2: 0.3: 0.03;
the component of the group B oil phase is the same as that of the group B oil phase in example 1, except that the mass ratio of the organic sunscreen agent to the grease to the skin-feel modifier to the emulsifier to the antioxidant is 26: 12: 0.1: 5: 0.15;
the component C is the same as the component in the example 1;
the component D is the same as in example 1;
the component E is the same as the component in example 1, except that the mass ratio of the phenoxyethanol to the dipotassium glycyrrhizinate to the silica to the methylene bis-benzotriazole tetramethyl butylphenol is 0.4: 0.15: 4: 6.
the oil-in-water sunscreen was prepared as in example 1.
Example 3
Example 3 provides an oil-in-water sunscreen comprising, by weight, 52 parts of a group a water phase component, 40 parts of a group B oil phase component, 0.6 part of a group C component, 1 part of a group D component, 17 parts of a group E component;
the aqueous phase components of group a were the same as in example 1, except that the mass ratio of water, glycerin, butylene glycol, carbomer, xanthan gum, and sodium hyaluronate was 34: 3: 4: 0.15: 0.2: 0.02;
the component of the oil phase in the group B is the same as that in example 1, except that the mass ratio of the organic sunscreen agent to the grease to the skin-feel modifier to the emulsifier to the antioxidant is 25.5: 10: 0.05: 4: 0.1;
the component C is the same as the component in the example 1;
the component D is the same as in example 1;
the component E is the same as the component in example 1, except that the mass ratio of the phenoxyethanol to the dipotassium glycyrrhizinate to the silica to the methylene bis-benzotriazole tetramethyl butylphenol is 0.3: 0.1: 3: 5.
the oil-in-water sunscreen was prepared as in example 1.
Example 4
Example 4 provides an oil-in-water sunscreen as in example 3, except that the cetearyl glucoside and cetearyl alcohol are replaced with caprylic/capric triglyceride, which is purchased from oxsnow.
The oil-in-water sunscreen was prepared as in example 1.
Example 5
Example 5 provides an oil-in-water sunscreen as in example 3, except that the cetearyl glucoside and cetearyl alcohol, glyceryl stearate and PEG-100 stearate are present in half the original amount.
The oil-in-water sunscreen was prepared as in example 1.
Example 6
Example 6 provides an oil-in-water sunscreen similar to example 3, except that glyceryl stearate and PEG-100 stearate were replaced with cetyl PEG/PPG-10/1 dimethicone, which was purchased from New chemical company.
The oil-in-water sunscreen was prepared as in example 1.
Example 7
Example 7 provides an oil-in-water sunscreen as in example 3, except that triethanolamine is replaced with glycerol.
The oil-in-water sunscreen was prepared as in example 1.
Example 8
Example 8 provides an oil-in-water sunscreen as in example 3.
The preparation method of the oil-in-water sunscreen emulsion comprises the following steps:
s1: adding the water phase components of group A into an emulsifying pot, heating to 80-85 deg.C, stirring and homogenizing to completely dissolve;
s2: adding the group B oil phase components into an oil phase pot, heating to 80-85 ℃, and stirring to completely dissolve the group B oil phase components;
s3: adding the group B oil phase component treated by the S2 into the group A water phase component treated by the S2, homogenizing and emulsifying uniformly, stirring and cooling to 60 ℃ to obtain a mixture 1;
s4: and simultaneously adding the component C, the component D and the component E into the mixture 1 obtained in the step S3, stirring and homogenizing until the components are completely dissolved, and continuously cooling to 45 ℃ to obtain the oil-in-water sun block.
Performance testing
1. And (3) stability testing: the oil-in-water sunscreen emulsions described in examples 1-8 were subjected to stability tests in cycles of normal temperature, 5 deg.C, -18 deg.C and 48 deg.C and high and low temperatures, and stability was observed after taking out every week and returning to normal temperature, and the test results are shown in Table 1.
2. And (3) centrifugal test: the sunscreen emulsions described in examples 1 to 8 were placed in a centrifuge and operated at 3000 rpm for 30min, and then the separation and stratification were observed, and the test results are shown in Table 1.
TABLE 1
Stability test | Centrifugal test | |
Example 1 | Stabilization | Stabilization |
Example 2 | Stabilization | Stabilization |
Example 3 | Stabilization | Stabilization |
Example 4 | Oil production at high and low temperatures of 2 weeks | Layering |
Example 5 | 2 weeks high and Low temperatureOil appearance | Layering |
Example 6 | Oil production at high and low temperatures of 2 weeks | Layering |
Example 7 | Oil production at high and low temperatures of 2 weeks | Layering |
Example 8 | Stabilization | Stabilization |
3. In vitro sun protection index: the oil-in-water sunscreen emulsions described in examples 1-8 were tested for in vitro Sun Protection Factor (SPF) according to the COLIPA Method (2011) standard, and the results are shown in table 3.
4. Evaluation of the degree of freshness: 36 volunteers with healthy skin, regardless of male and female, were randomly selected from a group of 6 individuals to try the oil-in-water sunscreen emulsions described in examples 1-8, and the refreshing degree was evaluated according to the evaluation criteria in Table 2, with the score ranging from 1 to 5, the larger the value, the deeper the degree, and the test results are shown in Table 3.
5. Evaluation of spreadability: 36 volunteers with healthy skin, regardless of male and female, are selected from the oil-in-water sun block described in examples 1-8, a group of 6 persons is randomly selected for trial use, the spreadability evaluation is carried out according to the evaluation standard of table 2, the score ranges from 1 to 5, the larger the value is, the deeper the degree is, and the test result is shown in table 3.
TABLE 2
TABLE 3
SPF value | Degree of freshness | Spreadability | |
Example 1 | 157.64 | 3.2 | 3.5 |
Example 2 | 171.47 | 3.4 | 3.4 |
Example 3 | 148.14 | 3.7 | 3.8 |
Example 4 | 47.80 | 3.0 | 3.0 |
Example 5 | 58.63 | 2.7 | 2.8 |
Example 6 | 56.91 | 2.5 | 2.4 |
Example 7 | 87.19 | 2.8 | 2.5 |
Example 8 | 170.79 | 3.4 | 3.2 |
The foregoing examples are merely illustrative and serve to explain some of the features of the method of the present invention. The appended claims are intended to claim as broad a scope as is contemplated, and the examples presented herein are merely illustrative of selected implementations in accordance with all possible combinations of examples. Accordingly, it is applicants' intention that the appended claims are not to be limited by the choice of examples illustrating features of the invention. Also, where numerical ranges are used in the claims, subranges therein are included, and variations in these ranges are also to be construed as possible being covered by the appended claims.
Claims (10)
1. The oil-in-water sunscreen emulsion is characterized by comprising, by weight, 45-60 parts of a group A water phase component, 35-45 parts of a group B oil phase component, 0.5-0.8 part of a group C component, 0.5-1.5 parts of a group D component and 15-20 parts of a group E component; the group B oil phase component is selected from one or more of organic sunscreen agent, grease, skin feel regulator, emulsifier and antioxidant; the emulsifier comprises an O/W nonionic emulsifier with HLB value of 10-13.
2. The oil-in-water sunscreen emulsion according to claim 1, wherein in the component of the oil phase in the group B, the mass ratio of the organic sunscreen agent, the grease, the skin feel modifier, the emulsifier and the antioxidant is (20-26): (8-12): (0.01-0.1): (3-5): (0.05-0.15).
3. The oil-in-water sunscreen according to claim 2 wherein the organic sunscreen is selected from one or more of ethylhexyl methoxycinnamate, homosalate, octocrylene, ethylhexyl salicylate, hexyl diethylaminobenzoyl formate, bis-ethylhexyloxyphenol methoxyphenyl triazine.
4. The oil-in-water sunscreen according to claim 1 wherein the emulsifier further comprises cetearyl glucoside and cetearyl alcohol.
5. The oil-in-water sunscreen according to claim 1 wherein the O/W nonionic emulsifier having an HLB value of 10-13 is glyceryl stearate and PEG-100 stearate.
6. The oil-in-water sunscreen as claimed in claim 1 wherein the oil comprises one or more of cyclopentadimethylsiloxane, isononyl isononanoate, C12-15 alcohol benzoate, hydrogenated polyisobutene.
7. The oil-in-water sunscreen according to claim 1 wherein the group a aqueous phase components comprise water, glycerin, butylene glycol, carbomer, xanthan gum, sodium hyaluronate; the mass ratio of the water, the glycerin, the butanediol, the carbomer, the xanthan gum and the sodium hyaluronate is (30-40): (2-4): (1-3): (0.1-0.2): (0.1-0.3): (0.01-0.03).
8. The oil-in-water sunscreen emulsion according to any of claims 1 to 7 wherein the E component is selected from one or more of phenoxyethanol, dipotassium glycyrrhizinate, silica, methylene bis-benzotriazole tetramethylbutylphenol.
9. The oil-in-water sunscreen emulsion according to claim 8, wherein the mass ratio of phenoxyethanol to dipotassium glycyrrhizinate to silica to methylene bis-benzotriazole tetramethylbutylphenol is (0.2-0.4): (0.05-0.15): (2-4): (4-6).
10. A method for preparing the oil-in-water sunscreen according to claim 8, comprising the steps of:
s1: adding the water phase components of group A into an emulsifying pot, heating to 80-85 deg.C, stirring and homogenizing to completely dissolve;
s2: adding the group B oil phase components into an oil phase pot, heating to 80-85 ℃, and stirring to completely dissolve the group B oil phase components;
s3: adding the group B oil phase component treated by the S2 into the group A water phase component treated by the S2, homogenizing and emulsifying uniformly, stirring and cooling to 55-65 ℃ to obtain a mixture 1;
s4: adding the component C into the mixture 1 obtained in the step S3, stirring and homogenizing until the component C is completely dissolved, and continuously cooling to 40-50 ℃ to obtain a mixture 2;
s5: mixing and dissolving the component D completely, then adding the component D into the mixture 2 obtained in the step S4, and stirring and mixing the component D until the component D is completely dissolved to obtain a mixture 3;
s6: pre-dispersing methylene bis-benzotriazole tetramethyl butyl phenol by water according to a ratio of 1:2, adding the component E into the mixture 3 obtained in the step S5, and stirring and mixing until the component E is completely dissolved to obtain the oil-in-water sun-block emulsion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011406371.1A CN112315820A (en) | 2020-12-02 | 2020-12-02 | Oil-in-water sunscreen emulsion and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011406371.1A CN112315820A (en) | 2020-12-02 | 2020-12-02 | Oil-in-water sunscreen emulsion and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112315820A true CN112315820A (en) | 2021-02-05 |
Family
ID=74302158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011406371.1A Pending CN112315820A (en) | 2020-12-02 | 2020-12-02 | Oil-in-water sunscreen emulsion and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112315820A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559003A (en) * | 2021-07-01 | 2021-10-29 | 宝萃生物科技有限公司 | Sunscreen composition with high UVA protection effect and application thereof |
CN114042002A (en) * | 2021-12-13 | 2022-02-15 | 广东馨柯生命科学有限公司 | Mild and full-green sun block capable of remarkably increasing SPF (specific pathogen free) and preparation method thereof |
CN115487092A (en) * | 2022-09-21 | 2022-12-20 | 广东鼎月生物科技有限公司 | Isolation sunscreen cream and preparation method thereof |
CN115887307A (en) * | 2022-11-30 | 2023-04-04 | 江苏优度生物科技有限公司 | A kind of sunscreen lotion and preparation method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107625654A (en) * | 2017-10-20 | 2018-01-26 | 佛山娇芙生物科技有限公司 | A kind of efficiently water-in-oil type sunscreen and preparation method thereof |
CN108542803A (en) * | 2018-04-16 | 2018-09-18 | 杭州心悦化妆品有限公司 | A kind of sun-screening agent and its preparation process |
CN109199954A (en) * | 2018-10-25 | 2019-01-15 | 广州睿森生物科技有限公司 | A kind of isolation ultra light sun block lotion and preparation method thereof |
CN109453064A (en) * | 2018-12-10 | 2019-03-12 | 苏州绿叶日用品有限公司 | The frangible cosmetic composition and preparation method thereof removed of the anti-sweat warm water of waterproof |
CN109730938A (en) * | 2018-12-24 | 2019-05-10 | 深圳市琉璃光生物科技有限公司 | A kind of oil-in-water type sunscreen and preparation method thereof |
CN110063901A (en) * | 2019-03-18 | 2019-07-30 | 曼秀雷敦(中国)药业有限公司 | A kind of sunscreen cream suitable for sensitive skin and preparation method thereof |
CN110075007A (en) * | 2019-06-06 | 2019-08-02 | 广州微肽生物科技有限公司 | With waterproof, the oil-in-water sunscreen product for improving skin elasticity and preparation method thereof |
CN110074989A (en) * | 2019-05-13 | 2019-08-02 | 广东蕾琪化妆品有限公司 | A kind of sunscreen and preparation method thereof of high sun-proof value |
CN111714386A (en) * | 2020-07-21 | 2020-09-29 | 上海新高姿化妆品有限公司 | High-power sunscreen composition and preparation method thereof |
-
2020
- 2020-12-02 CN CN202011406371.1A patent/CN112315820A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107625654A (en) * | 2017-10-20 | 2018-01-26 | 佛山娇芙生物科技有限公司 | A kind of efficiently water-in-oil type sunscreen and preparation method thereof |
CN108542803A (en) * | 2018-04-16 | 2018-09-18 | 杭州心悦化妆品有限公司 | A kind of sun-screening agent and its preparation process |
CN109199954A (en) * | 2018-10-25 | 2019-01-15 | 广州睿森生物科技有限公司 | A kind of isolation ultra light sun block lotion and preparation method thereof |
CN109453064A (en) * | 2018-12-10 | 2019-03-12 | 苏州绿叶日用品有限公司 | The frangible cosmetic composition and preparation method thereof removed of the anti-sweat warm water of waterproof |
CN109730938A (en) * | 2018-12-24 | 2019-05-10 | 深圳市琉璃光生物科技有限公司 | A kind of oil-in-water type sunscreen and preparation method thereof |
CN110063901A (en) * | 2019-03-18 | 2019-07-30 | 曼秀雷敦(中国)药业有限公司 | A kind of sunscreen cream suitable for sensitive skin and preparation method thereof |
CN110074989A (en) * | 2019-05-13 | 2019-08-02 | 广东蕾琪化妆品有限公司 | A kind of sunscreen and preparation method thereof of high sun-proof value |
CN110075007A (en) * | 2019-06-06 | 2019-08-02 | 广州微肽生物科技有限公司 | With waterproof, the oil-in-water sunscreen product for improving skin elasticity and preparation method thereof |
CN111714386A (en) * | 2020-07-21 | 2020-09-29 | 上海新高姿化妆品有限公司 | High-power sunscreen composition and preparation method thereof |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559003A (en) * | 2021-07-01 | 2021-10-29 | 宝萃生物科技有限公司 | Sunscreen composition with high UVA protection effect and application thereof |
CN113559003B (en) * | 2021-07-01 | 2022-08-02 | 宝萃生物科技有限公司 | Sunscreen composition with high UVA protection effect and application thereof |
CN114042002A (en) * | 2021-12-13 | 2022-02-15 | 广东馨柯生命科学有限公司 | Mild and full-green sun block capable of remarkably increasing SPF (specific pathogen free) and preparation method thereof |
CN115487092A (en) * | 2022-09-21 | 2022-12-20 | 广东鼎月生物科技有限公司 | Isolation sunscreen cream and preparation method thereof |
CN115487092B (en) * | 2022-09-21 | 2023-12-15 | 广东鼎月生物科技有限公司 | Isolation sun cream and preparation method thereof |
CN115887307A (en) * | 2022-11-30 | 2023-04-04 | 江苏优度生物科技有限公司 | A kind of sunscreen lotion and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112315820A (en) | Oil-in-water sunscreen emulsion and preparation method thereof | |
KR102170764B1 (en) | Cosmetic Composition Contaning Active Ingredient Stabilized By Nano-Structured Lipid Carrier | |
US20090098070A1 (en) | Sunscreen compositions with low eye-sting and high spf | |
CN114939083A (en) | Sunscreen agent and preparation method thereof | |
AU655790B2 (en) | Novel compositions | |
EP2377508A1 (en) | Cosmetic O/W emulsion for skin care | |
CN112451395A (en) | Water-in-oil sunscreen emulsion and preparation method thereof | |
ES2639289T3 (en) | Cosmetic sunscreen emulsified oil-in-water type | |
CN113925791A (en) | Waterproof sunscreen composition and preparation method thereof | |
CN113081906B (en) | Astaxanthin composition and preparation method and application thereof | |
CN109562136A (en) | It treats skin disorder or mitigates the method for skin disorder seriousness | |
KR20160082054A (en) | Emulsifier-Free Cosmetic Composition of the Oil-in-Water Emulsion Type and Preparation Method Thereof | |
US20100055054A1 (en) | Self tanning compositions containing oils | |
CN117503626B (en) | Plant-derived sun-screening synergistic composition, sun-screening product, preparation method and application | |
DE10036051A1 (en) | Cosmetic or dermatological preparations for treating sun-tanning contain chitosan and lecithin to delay vaporization of volatile components | |
CN109568178A (en) | A kind of nanometer of micro emulsion composition and its nano micro-emulsification cosmetic of preparation | |
RU2428167C2 (en) | Preparation for external application on skin, which possesses higher stability | |
CN107028774B (en) | Heat stable suspension cosmetic composition | |
JP2019178126A (en) | Ultraviolet absorber-containing composition and cosmetics containing the same | |
KR20220143075A (en) | Topically administrable lysate (Ly) of retrodifferentiated cells of the plant Helichrysum stoechas for eliminating or reducing skin inflammation | |
JP5930142B1 (en) | Liquid composition containing mannosyl erythritol lipid-B | |
KR102390010B1 (en) | Anti-irritant cosmetic composition containing guar gum derivative | |
JP2781626B2 (en) | Solubilized transparent cosmetic | |
KR102502255B1 (en) | Azulene emulsion composition for wound healing, skin regeneration or irritation alleviation effect, and preparing method of the same | |
KR20040078499A (en) | Cosmetic Composition for Screening UV Rays and Preventing Skin-Aging Comprising Ferulic Acid and Peach Blossom Extracts As Active Ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |